Evaluation of variable new antigen receptors (vNARs) as a novel cathepsin S (CTSS) targeting strategy

Overview of attention for article published in Frontiers in Pharmacology, December 2023

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (74th percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

So far, Altmetric has seen 6 X posts from 6 X users, with an upper bound of 11,996 followers.

Evaluation of variable new antigen receptors (vNARs) as a novel cathepsin S (CTSS) targeting strategy https://t.co/gm4wkDLHkh

RT @dr_rburden: Delighted to have been involved in this fab project with colleagues from @QubPGJCCR, @pharmacyatQUB and @ElasmogenLtd focus…

RT @dr_rburden: Delighted to have been involved in this fab project with colleagues from @QubPGJCCR, @pharmacyatQUB and @ElasmogenLtd focus…

RT @FrontPharmacol: New Research: Evaluation of variable new antigen receptors (vNARs) as a novel cathepsin S (CTSS) targeting strategy htt…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.